Lina Lu

Title: Lina Lu - Innovator in Tolerogenic Dendritic Cell Research

Lina Lu is an accomplished inventor based in Allison Park, Pennsylvania. She has made significant contributions to the field of immunology through her innovative research and patent work.

Latest Patents

Lina Lu holds a patent titled "Use of tolerogenic dendritic cells for enhancing tolerogenicity in a host and methods for making the same." This invention focuses on tolerogenic mammalian dendritic cells (DCs) and outlines methods for their production. The patent describes a method for enhancing tolerogenicity in a host by administering these specialized DCs. The tolerogenic DCs include an oligodeoxyribonucleotide (ODN) with NF-κB binding sites and may also incorporate a viral vector, such as an adenoviral vector, which does not compromise their tolerogenic properties. This advancement is particularly beneficial for prolonging foreign graft survival and treating inflammatory-related diseases, including autoimmune disorders.

Career Highlights

Lina Lu is affiliated with the University of Pittsburgh, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential applications in medical treatments and therapies.

Collaborations

Lina collaborates with notable colleagues, including Paul David Robbins and Nick Giannoukakis. Their combined expertise enhances the research efforts and contributes to the advancement of knowledge in the field.

Conclusion

Lina Lu's innovative work in the area of tolerogenic dendritic cells represents a significant advancement in immunology. Her contributions have the potential to impact the treatment of various inflammatory diseases and improve graft survival rates.